Literature DB >> 21555747

Balancing the risks and benefits of proton pump inhibitors.

James M Gill, Marty S Player, David C Metz.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21555747      PMCID： PMC3090427          DOI： 10.1370/afm.1269

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN： 1544-1709            Impact factor:   5.166


× No keyword cloud information.
  19 in total

Review 1.  Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.

Authors:  M M Wolfe; G Sachs
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

2.  Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.

Authors:  Kenneth R DeVault; Donald O Castell
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

3.  American Gastroenterological Association medical position statement: evaluation of dyspepsia.

Authors:  Nicholas J Talley
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

4.  Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals.

Authors:  W P J den Elzen; Y Groeneveld; W de Ruijter; J H M Souverijn; S le Cessie; W J J Assendelft; J Gussekloo
Journal:  Aliment Pharmacol Ther       Date:  2008-01-10       Impact factor: 8.171

Review 5.  Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years.

Authors:  J L Wallace
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

6.  Long-term proton pump inhibitor therapy and risk of hip fracture.

Authors:  Yu-Xiao Yang; James D Lewis; Solomon Epstein; David C Metz
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

Review 7.  On-demand therapy for gastroesophageal reflux disease.

Authors:  David C Metz; John M Inadomi; Colin W Howden; Sander J Veldhuyzen van Zanten; Peter Bytzer
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

8.  Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.

Authors:  Walter Smalley; C Michael Stein; Patrick G Arbogast; Glenn Eisen; Wayne A Ray; Marie Griffin
Journal:  Arthritis Rheum       Date:  2002-08

9.  Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.

Authors:  T Poynard; M Lemaire; H Agostini
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-07       Impact factor: 2.566

Review 10.  Systematic review of the risk of enteric infection in patients taking acid suppression.

Authors:  Jennifer Leonard; John K Marshall; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2007-05-17       Impact factor: 10.864
View more
  2 in total

1.  Improving prescribing for older patients - 'Yes S-I-R-E!'

Authors:  Ting Ting Selina Cheong; Sharifah Munirah Alhamid; Fu Yin Li; Swee Tee Wendy Ang; Kim Hwa Jim Lim
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

Review 2.  Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?

Authors:  Laura Targownik
Journal:  Am J Gastroenterol       Date:  2018-03-20       Impact factor: 10.864
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.